{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:29Z","timestamp":1786167809210,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005639","name":"Universidade De S\u00e3o Paulo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005639","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Medulloblastoma (MB), the most common malignant pediatric brain tumor, is classified into four molecular groups: WNT, SHH, G3, and G4. G3 and G4 MBs are characterized by poor prognosis and high metastatic potential. Although USP2 (ubiquitin-specific peptidase 2) has been described as a prognostic biomarker and a promising therapeutic target in several cancer types, its role in the pathogenesis of G3 and G4 MBs remains unexplored. In this study, USP2 expression was investigated through in silico analyses, public datasets (GSE85217), and tumor samples from 54 pediatric MB patients. In addition, the effects of USP2 inhibition were evaluated in two G3\/G4 MB cell lines (D283 Med and USP-13) using ML364, a selective USP2 inhibitor. USP2 was overexpressed in G3 and G4 MBs and was associated with metastasis and unfavorable clinical outcomes. Furthermore, ML364 treatment reduced USP2 protein expression level, as well as cell viability, migration, invasion, and colony-forming capacity in both cell lines. These findings indicate that USP2 is upregulated in pediatric G3 and G4 MBs and support its potential role as a biomarker of poor prognosis and a therapeutic target in these molecular subgroups.<\/jats:p>","DOI":"10.1007\/s12311-026-02051-w","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:40:07Z","timestamp":1783575607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-2835","authenticated-orcid":false,"given":"Jonas Jos\u00e9","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9654-2247","authenticated-orcid":false,"given":"Manuela Eduarda","family":"de Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-2360","authenticated-orcid":false,"given":"Alcides Euzebio Tavares","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9535-5204","authenticated-orcid":false,"given":"Mariane Minussi","family":"Baptistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-1248","authenticated-orcid":false,"given":"Eduardo Afonso","family":"da Silva Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-5287","authenticated-orcid":false,"given":"Marina Ferreira","family":"C\u00e2ndido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4313-9347","authenticated-orcid":false,"given":"Luis Fernando Peinado","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6855-5200","authenticated-orcid":false,"given":"J\u00e9ssica Oliveira","family":"de Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane Gomes","family":"de Paula Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-9852","authenticated-orcid":false,"given":"Silvia Regina","family":"Brandalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-3525","authenticated-orcid":false,"given":"Jos\u00e9 Andres","family":"Yunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-4211","authenticated-orcid":false,"given":"Luiz Gonzaga","family":"Tone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-429X","authenticated-orcid":false,"given":"Elvis Terci","family":"Valera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0652-728X","authenticated-orcid":false,"given":"Pablo Shimaoka","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-789X","authenticated-orcid":false,"given":"Carlos Alberto","family":"Scrideli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2051_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0063-6","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma Nat Rev Dis Primers. 2019. https:\/\/doi.org\/10.1038\/s41572-019-0063-6.","journal-title":"Medulloblastoma Nat Rev Dis Primers"},{"key":"2051_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017;547:311\u20137. https:\/\/doi.org\/10.1038\/nature22973.","journal-title":"Nature"},{"key":"2051_CR3","doi-asserted-by":"publisher","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell. 2017; https:\/\/doi.org\/10.1016\/j.ccell.2017.05.005.","DOI":"10.1016\/j.ccell.2017.05.005"},{"key":"2051_CR4","doi-asserted-by":"publisher","unstructured":"Kool M, Jones DT, J\u00e4ger N, Northcott PA, Pugh TJ, Hovestadt V, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 2014;2014. https:\/\/doi.org\/10.1016\/j.ccr.2014.02.004.","DOI":"10.1016\/j.ccr.2014.02.004"},{"key":"2051_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09854-1","author":"O Menyh\u00e1rt","year":"2020","unstructured":"Menyh\u00e1rt O, Gy\u0151rffy B. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches. Cancer Metastasis Rev. 2020. https:\/\/doi.org\/10.1007\/s10555-020-09854-1.","journal-title":"Cancer Metastasis Rev"},{"key":"2051_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-022-01217-4","author":"A Martins-da-Silva","year":"2023","unstructured":"Martins-da-Silva A, Baroni M, Salom\u00e3o KB, das Chagas PF, Bonfim-Silva R, Geron L, et al. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma. Cell Mol Neurobiol. 2023. https:\/\/doi.org\/10.1007\/s10571-022-01217-4.","journal-title":"Cell Mol Neurobiol"},{"key":"2051_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3207-7","author":"Q Qu","year":"2015","unstructured":"Qu Q, Mao Y, Xiao G, Fei X, Wang J, Zhang Y, et al. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines. Tumour Biol. 2015. https:\/\/doi.org\/10.1007\/s13277-015-3207-7.","journal-title":"Tumour Biol"},{"key":"2051_CR8","doi-asserted-by":"publisher","unstructured":"Ke HL, Lee YC, Li WM, Wang CS, Hsu WC, Lin HH et al. (2022) High ubiquitin-specific protease 2a expression level predicts poor prognosis in upper tract urothelial carcinoma. Appl Immunohistochem Mol Morphol. 2022. https:\/\/doi.org\/10.1097\/PAI.0000000000001014.","DOI":"10.1097\/PAI.0000000000001014"},{"key":"2051_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101109","author":"F Zhang","year":"2021","unstructured":"Zhang F, Zhao Y, Sun Y. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates. J Biol Chem. 2021. https:\/\/doi.org\/10.1016\/j.jbc.2021.101109.","journal-title":"J Biol Chem"},{"key":"2051_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122409","author":"T Feng","year":"2024","unstructured":"Feng T, Wang P, Zhang X. Skp2: A critical molecule for ubiquitination and its role in cancer. Life Sci. 2024. https:\/\/doi.org\/10.1016\/j.lfs.2023.122409.","journal-title":"Life Sci"},{"key":"2051_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2347","author":"IM Chu","year":"2008","unstructured":"Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008. https:\/\/doi.org\/10.1038\/nrc2347.","journal-title":"Nat Rev Cancer"},{"key":"2051_CR12","first-page":"504","volume":"23","author":"Y Yang","year":"2007","unstructured":"Yang Y, Hou JQ, Qu LY, Wang GQ, Ju HW, Zhao ZW, et al. [Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007;23:504\u20136.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"2051_CR13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0219","author":"B Benassi","year":"2012","unstructured":"Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, et al. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov. 2012. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0219.","journal-title":"Cancer Discov"},{"key":"2051_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.007","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wang X, Wang Q, Deng Y, Li K, Zhang M, et al. USP2a Supports Metastasis by Tuning TGF-\u03b2 Signaling. Cell Rep. 2018. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.007.","journal-title":"Cell Rep"},{"key":"2051_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00568-8","author":"B Xiong","year":"2021","unstructured":"Xiong B, Huang J, Liu Y, Zou M, Zhao Z, Gong J, et al. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A. Cell Oncol (Dordr). 2021. https:\/\/doi.org\/10.1007\/s13402-020-00568-8.","journal-title":"Cell Oncol (Dordr)"},{"key":"2051_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02112-w","author":"XQ Liu","year":"2022","unstructured":"Liu XQ, Shao XR, Liu Y, Dong ZX, Chan SH, Shi YY, et al. Tight junction protein 1 promotes vasculature remodeling via regulating USP2\/TWIST1 in bladder cancer. Oncogene. 2022. https:\/\/doi.org\/10.1038\/s41388-021-02112-w.","journal-title":"Oncogene"},{"key":"2051_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0681-y","author":"GAV Cruzeiro","year":"2019","unstructured":"Cruzeiro GAV, Salom\u00e3o KB, de Biagi CAO, Baumgartner M, Sturm D, Lira RCP, et al. A simplified approach using Taqman low-density array for medulloblastoma subgrouping. Acta Neuropathol Commun. 2019. https:\/\/doi.org\/10.1186\/s40478-019-0681-y.","journal-title":"Acta Neuropathol Commun"},{"key":"2051_CR18","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","author":"KJ Livak","year":"2021","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2021. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"2051_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.339","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006. https:\/\/doi.org\/10.1038\/nprot.2006.339.","journal-title":"Nat Protoc"},{"key":"2051_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1301679","author":"E Stensvold","year":"2017","unstructured":"Stensvold E, Krossnes BK, Lundar T, Due-T\u00f8nnessen BJ, Fri\u010d R, Due-T\u00f8nnessen P, et al. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment. Acta Oncol. 2017. https:\/\/doi.org\/10.1080\/0284186X.2017.1301679.","journal-title":"Acta Oncol"},{"key":"2051_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-018-0462-5","author":"L Holmes","year":"2018","unstructured":"Holmes L, Chavan P, Blake T, Dabney K. Unequal Cumulative Incidence and Mortality Outcome in Childhood Brain and Central Nervous System Malignancy in the USA. J Racial Ethn Health Disparities. 2018. https:\/\/doi.org\/10.1007\/s40615-018-0462-5.","journal-title":"J Racial Ethn Health Disparities"},{"key":"2051_CR22","doi-asserted-by":"publisher","DOI":"10.3171\/2019.5.PEDS18381","author":"K Juraschka","year":"2019","unstructured":"Juraschka K, Taylor MD. Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr. 2019. https:\/\/doi.org\/10.3171\/2019.5.PEDS18381.","journal-title":"J Neurosurg Pediatr"},{"key":"2051_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.10.018","author":"J Shan","year":"2009","unstructured":"Shan J, Zhao W, Gu W. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell. 2009. https:\/\/doi.org\/10.1016\/j.molcel.2009.10.018.","journal-title":"Mol Cell"},{"key":"2051_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-021-04348-5","author":"Z Xiao","year":"2021","unstructured":"Xiao Z, Liu Y, Li Q, Liu Q, Luo Y, Wei S. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer. Cancer Chemother Pharmacol. 2021. https:\/\/doi.org\/10.1007\/s00280-021-04348-5.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2051_CR25","doi-asserted-by":"publisher","DOI":"10.3892\/or.2023.8613","author":"S Zhang","year":"2023","unstructured":"Zhang S, Guo Y, Wang Z, Zhang Y, Zuo S. Targeting the deubiquitinase. Oncol Rep. 2023. https:\/\/doi.org\/10.3892\/or.2023.8613.","journal-title":"Oncol Rep"},{"key":"2051_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-0538-8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Liu S, Li Q, Shi Y, Wu Y, Liu F, et al. The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death Differ. 2020. https:\/\/doi.org\/10.1038\/s41418-020-0538-8.","journal-title":"Cell Death Differ"},{"key":"2051_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16162","author":"Q Xu","year":"2021","unstructured":"Xu Q, Liu M, Zhang F, Liu X, Ling S, Chen X, et al. Ubiquitin-specific protease 2 regulates Ang \u2161-induced cardiac fibroblasts activation by up-regulating cyclin D1 and stabilizing \u03b2-catenin in vitro. J Cell Mol Med. 2021. https:\/\/doi.org\/10.1111\/jcmm.16162.","journal-title":"J Cell Mol Med"},{"key":"2051_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2044651","author":"W Xiao","year":"2022","unstructured":"Xiao W, Wang J, Wang X, Cai S, Guo Y, Ye L, Li D, et al. Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. Autophagy. 2022. https:\/\/doi.org\/10.1080\/15548627.2022.2044651.","journal-title":"Autophagy"},{"key":"2051_CR29","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-11265-7","author":"TW Lin","year":"2022","unstructured":"Lin TW, Lee HY, Yang SF, Li CC, Ke HL, Li WM, et al. Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy. Ann Surg Oncol. 2022. https:\/\/doi.org\/10.1245\/s10434-021-11265-7.","journal-title":"Ann Surg Oncol"},{"key":"2051_CR30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.738567","author":"MI Davis","year":"2016","unstructured":"Davis MI, Pragani R, Fox JT, Shen M, Parmar K, Gaudiano EF, et al. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models. J Biol Chem. 2016. https:\/\/doi.org\/10.1074\/jbc.M116.738567.","journal-title":"J Biol Chem"},{"key":"2051_CR31","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.21637","author":"HQ Zhu","year":"2015","unstructured":"Zhu HQ, Gao FH. The Molecular Mechanisms of Regulation on USP2\u2019s Alternative Splicing and the Significance of Its Products. Int J Biol Sci. 2015. https:\/\/doi.org\/10.7150\/ijbs.21637.","journal-title":"Int J Biol Sci"},{"key":"2051_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107222","author":"Y Son","year":"2024","unstructured":"Son Y, Su Yang J, Chul Shin S, Kyoung Park S, Kim Y, Park J, et al. Structural optimization and biological evaluation of ML364 based derivatives as USP2a inhibitors. Bioorg Chem. 2024. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107222.","journal-title":"Bioorg Chem"},{"key":"2051_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612816","author":"TG Lee","year":"2023","unstructured":"Lee TG, Woo SM, Seo SU, Kim S, Park JW, Chang YC, et al. Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241612816.","journal-title":"Int J Mol Sci"},{"key":"2051_CR34","doi-asserted-by":"publisher","DOI":"10.4161\/cc.11.6.19550","author":"J Kim","year":"2012","unstructured":"Kim J, Kim WJ, Liu Z, Loda M, Freeman MR. The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle. 2012. https:\/\/doi.org\/10.4161\/cc.11.6.19550.","journal-title":"Cell Cycle"},{"key":"2051_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031209","author":"H Kitamura","year":"2021","unstructured":"Kitamura H, Hashimoto M. USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22031209.","journal-title":"Int J Mol Sci"},{"key":"2051_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.717370","author":"J Wang","year":"2021","unstructured":"Wang J, Ding J, Zhang S, Chen X, Yan S, Zhang Y, et al. Decreased USP2a Expression Inhibits Trophoblast Invasion and Associates With Recurrent Miscarriage. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.717370.","journal-title":"Front Immunol"},{"key":"2051_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04855-3","author":"C Wei","year":"2023","unstructured":"Wei C, Zhao X, Zhang H, Wang L. USP2 promotes cell proliferation and metastasis in choroidal melanoma via stabilizing Snail. J Cancer Res Clin Oncol. 2023. https:\/\/doi.org\/10.1007\/s00432-023-04855-3.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2051_CR38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101914RR","author":"M Zhu","year":"2022","unstructured":"Zhu M, Wang H, Ding Y, Yang Y, Xu Z, Shi L, et al. Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1. FASEB J. 2022. https:\/\/doi.org\/10.1096\/fj.202101914RR.","journal-title":"FASEB J"},{"key":"2051_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031211","author":"A Garc\u00eda-Osta","year":"2022","unstructured":"Garc\u00eda-Osta A, Dong J, Moreno-Aliaga MJ, Ramirez MJ. p27, The Cell Cycle and Alzheimer\u00b4s Disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031211.","journal-title":"Int J Mol Sci"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02051-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02051-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02051-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:10:09Z","timestamp":1786165809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02051-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02051-w","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the samples were collected after the patients or their legal guardians signed the informed consent form. This project was approved by the local Research Ethics Committee (CAAE no. 68159623.0.0000.5440).","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"107"}}